Sale!

AMT Gene Glycine Encephalopathy Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AMT Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AMT gene, which are linked to Glycine Encephalopathy, also known as Nonketotic Hyperglycinemia (NKH). This rare genetic disorder disrupts the normal metabolism of the amino acid glycine, leading to an accumulation in the body that can cause severe neurological symptoms, including intellectual disability, seizures, and hypotonia. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.

Performed at DNA Labs UAE, this test involves analyzing the patient’s DNA to detect mutations in the AMT gene that are responsible for the condition. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. By identifying the specific genetic alterations causing Glycine Encephalopathy, this test enables targeted interventions and supports families in understanding their genetic risk for future pregnancies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AMT Gene Glycine Encephalopathy Genetic Test

At DNA Labs UAE, we offer the AMT Gene Glycine Encephalopathy Genetic Test for the diagnosis of this rare genetic disorder. This test is crucial in identifying mutations or variations in the AMT gene that may be responsible for glycine encephalopathy, also known as nonketotic hyperglycinemia (NKH).

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology Nephrology Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the AMT Gene Glycine Encephalopathy Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by AMT Gene Glycine Encephalopathy NGS Genetic DNA Test gene AMT.

Test Details

The AMT gene is responsible for the production of the enzyme aminomethyltransferase. Glycine encephalopathy is a rare genetic disorder characterized by the accumulation of glycine in the brain and other tissues. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome.

NGS genetic testing can help identify mutations or variations in the AMT gene that may be causing glycine encephalopathy. This test aids in the diagnosis of the disorder and provides valuable information for treatment and management decisions. It is also useful for carrier testing and prenatal testing in families with a history of the disorder.

It is essential to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate guidance and interpretation of the results.

Test Name AMT Gene Glycine encephalopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AMT Gene Glycine encephalopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AMT Gene Glycine encephalopathy NGS Genetic DNA Test gene AMT
Test Details

The AMT gene is associated with the production of the enzyme aminomethyltransferase. Glycine encephalopathy, also known as nonketotic hyperglycinemia (NKH), is a rare genetic disorder characterized by the accumulation of glycine in the brain and other tissues.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of glycine encephalopathy, NGS genetic testing can be used to identify mutations or variations in the AMT gene that may be responsible for the disorder.

This type of genetic testing can help with the diagnosis of glycine encephalopathy and provide valuable information for treatment and management decisions. It can also be used for carrier testing and prenatal testing in families with a history of the disorder.

It’s important to note that genetic testing should always be done in consultation with a healthcare professional or genetic counselor who can provide appropriate guidance and interpretation of the results.